# Patriot National Bancorp Inc: financial statements, quarterly

PNBK · Nasdaq · CIK 1098146 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pnbk.md) · [Financials](/companies/pnbk/financials.md) · [Filings](/companies/pnbk/filings.md) · [Insiders](/companies/pnbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pnbk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [8.5](/filings/0001628280-23-039020.md) | [8.7 d](/filings/0001628280-24-013983.md) | [8.6](/filings/0001628280-24-023615.md) | [8.2](/filings/0001628280-24-036436.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(1.3)](/filings/0001628280-24-048517.md) | [0.4 d](/filings/0001628280-26-022508.md) | [0.1](/filings/0001628280-25-025485.md) | [(0.9)](/filings/0001628280-25-040370.md) | [24.6](/filings/0001628280-25-052358.md) | [(0.0) d](/filings/0001628280-26-022508.md) | [0.0](/filings/0001628280-26-035706.md) | [(0.0)](/filings/0001628280-26-057183.md) | [(0.0)](/filings/0001628280-25-052358.md) | [0.1 d](/filings/0001628280-26-022508.md) | [0.0](/filings/0001628280-26-035706.md) | [(1.5)](/filings/0001628280-26-057183.md) |
| Net income | $m | [(3.8)](/filings/0001628280-24-048517.md) | [0.9 d](/filings/0001628280-26-022508.md) | [(0.3)](/filings/0001628280-25-025485.md) | [(3.1)](/filings/0001628280-25-040370.md) | [(27.0)](/filings/0001628280-25-052358.md) | [(9.5) d](/filings/0001628280-26-022508.md) | [(2.8)](/filings/0001628280-26-035706.md) | [(5.0)](/filings/0001628280-26-057183.md) | [(2.7)](/filings/0001628280-25-052358.md) | [(2.3) d](/filings/0001628280-26-022508.md) | [(1.8)](/filings/0001628280-26-035706.md) | [0.1](/filings/0001628280-26-057183.md) |
| Diluted EPS | $ per share | [(0.95)](/filings/0001628280-24-048517.md) | not reported | [(0.08)](/filings/0001628280-25-025485.md) | [(0.77)](/filings/0001628280-25-040370.md) | [(6.78)](/filings/0001628280-25-052358.md) | not reported | [(0.21)](/filings/0001628280-26-035706.md) | [(0.06)](/filings/0001628280-26-057183.md) | [(0.03)](/filings/0001628280-25-052358.md) | not reported | [(0.02)](/filings/0001628280-26-035706.md) | [0.00](/filings/0001628280-26-057183.md) |
| Basic EPS | $ per share | [(0.95)](/filings/0001628280-24-048517.md) | not reported | [(0.08)](/filings/0001628280-25-025485.md) | [(0.77)](/filings/0001628280-25-040370.md) | [(6.78)](/filings/0001628280-25-052358.md) | not reported | [(0.21)](/filings/0001628280-26-035706.md) | [(0.06)](/filings/0001628280-26-057183.md) | [(0.03)](/filings/0001628280-25-052358.md) | not reported | [(0.02)](/filings/0001628280-26-035706.md) | [0.00](/filings/0001628280-26-057183.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [78.9](/filings/0001628280-23-039020.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,137](/filings/0001628280-23-039020.md) | [1,093](/filings/0001628280-25-017837.md) | [1,073](/filings/0001628280-24-023615.md) | [1,039](/filings/0001628280-24-036436.md) | [974](/filings/0001628280-24-048517.md) | [1,012](/filings/0001628280-26-022508.md) | [957](/filings/0001628280-25-025485.md) | [930](/filings/0001628280-25-040370.md) | [951](/filings/0001628280-25-052358.md) | [1,088](/filings/0001628280-26-057183.md) | [1,177](/filings/0001628280-26-035706.md) | [1,318](/filings/0001628280-26-057183.md) |
| Total liabilities | $m | [1,097](/filings/0001628280-23-039020.md) | [1,049](/filings/0001628280-25-017837.md) | [1,030](/filings/0001628280-24-023615.md) | [998](/filings/0001628280-24-036436.md) | [958](/filings/0001628280-24-048517.md) | [1,008](/filings/0001628280-26-022508.md) | [899](/filings/0001628280-25-025485.md) | [864](/filings/0001628280-25-040370.md) | [856](/filings/0001628280-25-052358.md) | [993](/filings/0001628280-26-057183.md) | [1,087](/filings/0001628280-26-035706.md) | [1,229](/filings/0001628280-26-057183.md) |
| Long-term debt | $m | not reported | [201](/filings/0001628280-25-017837.md) | not reported | not reported | not reported | [33.1](/filings/0001628280-26-022508.md) | not reported | not reported | not reported | [16.4](/filings/0001628280-26-022508.md) | not reported | not reported |
| Shareholders' equity | $m | [40.0](/filings/0001628280-24-048517.md) | [44.4](/filings/0001628280-26-022508.md) | [43.6](/filings/0001628280-25-040370.md) | [40.5](/filings/0001628280-25-052358.md) | [16.4](/filings/0001628280-25-052358.md) | [4.3](/filings/0001628280-26-057183.md) | [57.1](/filings/0001628280-26-057183.md) | [66.2](/filings/0001628280-26-057183.md) | [95.0](/filings/0001628280-25-052358.md) | [94.7](/filings/0001628280-26-057183.md) | [90.2](/filings/0001628280-26-057183.md) | [88.9](/filings/0001628280-26-057183.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(14.3) d](/filings/0001628280-24-048517.md) | [(0.2) d](/filings/0001628280-26-022508.md) | [1.8](/filings/0001628280-25-025485.md) | [6.0 d](/filings/0001628280-25-040370.md) | [(2.6) d](/filings/0001628280-25-052358.md) | [(2.6) d](/filings/0001628280-26-022508.md) | [(5.8)](/filings/0001628280-26-035706.md) | [0.9 d](/filings/0001628280-26-057183.md) | [(5.2) d](/filings/0001628280-25-052358.md) | [(4.0) d](/filings/0001628280-26-022508.md) | [(2.9)](/filings/0001628280-26-035706.md) | [(5.6) d](/filings/0001628280-26-057183.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001628280-24-048517.md) | [0.0 d](/filings/0001628280-26-022508.md) | [0.0](/filings/0001628280-25-025485.md) | [0.1 d](/filings/0001628280-25-040370.md) | [0.1 d](/filings/0001628280-25-052358.md) | [(0.1) d](/filings/0001628280-26-022508.md) | [0.1](/filings/0001628280-26-035706.md) | [0.0 d](/filings/0001628280-26-057183.md) | [0.0 d](/filings/0001628280-25-052358.md) | [0.1 d](/filings/0001628280-26-022508.md) | [0.5](/filings/0001628280-26-035706.md) | [0.0 d](/filings/0001628280-26-057183.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [4.0](/filings/0001628280-23-039020.md) | [4.0](/filings/0001628280-24-023615.md) | [4.0](/filings/0001628280-24-036436.md) | [4.0](/filings/0001628280-24-048517.md) | [4.0](/filings/0001628280-25-025485.md) | [4.0](/filings/0001628280-25-040370.md) | [4.0](/filings/0001628280-25-052358.md) | [13.3](/filings/0001628280-26-035706.md) | [78.1](/filings/0001628280-26-057183.md) | [99.9](/filings/0001628280-25-052358.md) | [115](/filings/0001628280-26-035706.md) | [117](/filings/0001628280-26-057183.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 118,742,200 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001628280-26-057183.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.